» Authors » Stephanie Fichtner

Stephanie Fichtner

Explore the profile of Stephanie Fichtner including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 59
Citations 1359
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lanz H, Strauss K, Hopler J, Kraft M, Hoffmann S, Binzenhofer L, et al.
J Cardiovasc Dev Dis . 2024 Oct; 11(10). PMID: 39452284
Background: MRI (magnetic resonance imaging) represents the diagnostic image modality of choice in several conditions. With an increasing number of patients requiring MRI for diagnostic purposes, the issue of safety...
2.
Vonthein R, Baldauf B, Borov S, Lau E, Giaccardi M, Assadian O, et al.
J Cardiothorac Surg . 2024 Oct; 19(1):592. PMID: 39367427
Introduction: Infection is a significant complication of cardiac implantable electronic device (CIED) therapy. The European TauroPace™ Registry investigates the safety and efficacy of TauroPace™ (TP), an antimicrobial solution containing taurolidine,...
3.
Fichtner S, Schmitt J
Herzschrittmacherther Elektrophysiol . 2023 Aug; 34(3):185-186. PMID: 37639058
No abstract available.
4.
Kellnar A, von Falkenhausen A, Fichtner S, Sinner M, Estner H, Lackermair K
Int J Cardiol . 2023 Aug; 390:131269. PMID: 37591414
Background: Current standards of ablation of premature ventricular complexes (PVC) combine modern hard- and software mapping and ablation features like multielectrode mapping catheters (MEC), contact force (CF) guided ablation catheters...
5.
Kellnar A, Fichtner S, Reitinger P, Sadoni S, Heyn O, Sams L, et al.
Int J Cardiol . 2023 Apr; 381:16-19. PMID: 37044179
Background: Implantable electronic cardiac devices (CIED) have emerged as an essential component in the treatment of cardiac arrhythmias and heart failure. Due to increased life expectancy, expanding indications and limited...
6.
Kellnar A, Fichtner S, Sams L, Stremmel C, Estner H, Lackermair K
Patient Prefer Adherence . 2023 Feb; 17:433-440. PMID: 36815129
Background: Treatment with wearable cardioverter defibrillators (WCD) is a non-invasive, transient therapy option for prevention of sudden cardiac death (SCD) in patients with temporary contraindications for implantation of a permanent...
7.
Thaler R, Sinner M, Joghetaei N, Fichtner S
HeartRhythm Case Rep . 2023 Jan; 9(1):28-30. PMID: 36685682
No abstract available.
8.
Lemmermohle E, Lackermair K, Klier I, Sadoni S, Heyn O, Hartrampf B, et al.
J Interv Card Electrophysiol . 2022 Dec; 66(5):1059-1061. PMID: 36577903
No abstract available.
9.
Thienel M, Haum M, Sadoni S, Novotny J, Estner H, Fichtner S, et al.
Patient Prefer Adherence . 2022 Nov; 16:3027-3033. PMID: 36387054
Background: The subcutaneous cardioverter defibrillator (S-ICD) has been shown to be a viable alternative to transvenous ICDs (TV-ICD) in all patients at risk of sudden cardiac death (SCD) but without...
10.
Lusebrink E, Binzenhofer L, Kellnar A, Scherer C, Schier J, Kleeberger J, et al.
J Am Heart Assoc . 2022 Oct; 11(21):e026539. PMID: 36285786
Cardiac arrest still accounts for a substantial proportion of cardiovascular related deaths and is associated with a tremendous risk of neurological injury and, among the few survivors, poor quality of...